Collegium Pharmaceutical, Inc. COLL Loans Payable, Noncurrent
Loans Payable, Noncurrent at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermLoansPayable.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s loans payable, noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s loans payable, noncurrent?
- Collegium Pharmaceutical, Inc. (COLL) reported loans payable, noncurrent of $531.72M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s loans payable, noncurrent changed year-over-year?
- Collegium Pharmaceutical, Inc.'s loans payable, noncurrent decreased by 0.7% year-over-year, from $535.7M to $531.72M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s loans payable, noncurrent?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s loans payable, noncurrent has grown at a 37.6% compound annual growth rate (CAGR), from $110.02M to $542.11M.
- What does loans payable, noncurrent mean?
- This represents the principal amount of long-term debt obligations, such as bank loans or credit facilities, that are due beyond one year. It reflects the company's long-term leverage position and its reliance on external financing to fund operations or strategic initiatives. Investors use this to evaluate the company's capital structure and long-term debt service capacity.